Home>Drug Target Models>Class A(Rhodopsin)

PTGER4

PTGER4 is a receptor for prostaglandin E2 (PGE2), widely expressed in immune tissues, vascular endothelium, bone cells and gastrointestinal mucosa. Activation of PTGER4 mediates Gs-cAMP and β-arrestin signaling, regulating anti-inflammatory response, vasodilation and immune suppression. PTGER4 is an important target for chronic inflammation and oncology drug discovery. Our PTGER4 stable cell lines are validated for cAMP assays to support your drug discovery programs.

Contact us

Name

Phone

Email*

Service & Products Interested*

Comments

submit
info@reqbio.com Email